Spark Therapeutics Inc Stock price Nasdaq
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | 0.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 17-04-30 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 17-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 19-12-16 |
Bruce Resnick
BRD | Director/Board Member | - | 19-12-16 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Spark Therapeutics, Inc.
- Stock Spark Therapeutics Inc - Nasdaq